España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Business Wire
BW LPG Limited - Audited Financial Statements 2024
BW LPG Limited ("BW LPG" or the "Company", OSE ticker code: "BWLPG.OL", NYSE ticker code: "BWLP") hereby publishes the Directors' Statement, Audited Financial Statements for the financial year ended 31 December 2024 and
Avolon Raises US$1.0 Billion in New Unsecured Bank Facility With Middle East Financial Institutions
Avolon Holdings Limited (‘Avolon'), a leading global aviation finance company, announces it has raised US$1.0 billion in a new unsecured dual tranche bank facility (the ‘Facility') with a syndicate of six banks in
Cartesian Growth Corporation III Announces Pricing of Upsized $240 Million Initial Public Offering
Cartesian Growth Corporation III (the "Company") announced today the pricing of its initial public offering of 24,000,000 units, upsized from 20,000,000 units, at a price of $10.00 per unit. The units are expected to
ATDM & AM CoE Summit Bolsters Defense Manufacturing Workforce and Partnerships
Leaders from across the defense and manufacturing sectors came together in Danville, Virginia, for the fourth annual joint summit hosted by the Accelerated Training in Defense Manufacturing (ATDM) program and the U.S.
InnoCare's Zurletrectinib Receives Priority Review from China's NMPA
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its new generation pan-TRK inhibitor zurletrectinib (ICP-723) has been
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual primary endpoints in the Phase 3 EPCORE® FL-1 trial Full results from the trial will be submitted for
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: National Funds Ticker Distribution Declaration- 5/1/2025 Ex-Date- 5/15/2025 Record-
LPRO Investors Have Opportunity to Lead Open Lending Corporation Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder
SmartStop Celebrates Winning Designs in North American Door Wrap Design Contest
SmartStop Self Storage REIT, Inc. ("SmartStop") (NYSE:SMA), an internally managed real estate investment trust and a premier owner and operator of self-storage facilities in the United States and Canada, is thrilled to
Autism Care Improves With Team-Based Caregiver Training, ACES Finds
Leading autism services provider finds meaningful differences between training approaches Children with autism have measurably better outcomes when their caregivers participate in team-based training, according to a
AEye Appoints Doron Simon to its Board of Directors
AEye, Inc. (NASDAQ:LIDR), a global leader in adaptive, high-performance lidar solutions, announced it has appointed Doron Simon to its Board of Directors effective April 29, 2025. Mr.
KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2025-5 (SEMT 2025-5)
KBRA assigns preliminary ratings to 60 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2025-5 (SEMT 2025-5), a $648.8 million prime RMBS transaction. The pool is comprised of 526 first-lien,
LifeCare Solutions and PATHS Partner to Deliver Scalable Dementia Caregiver Support for CMS GUIDE Model Success
Partnership combines expert dementia care education with PATHS' 24/7 digital platform to empower caregivers, equip care teams with real-time insights, and help GUIDE participants meet CMS goals at scale. LifeCare
Itility Group Acquires Majority Stake in Seamgen
Itility Group, a leading software and data solution provider in Manufacturing, Health, Energy, and AgriTech, is delighted to announce the acquisition of a majority stake in Seamgen, a global custom application
Cantor Equity Partners II, Inc. Announces Pricing of Upsized $240 Million Initial Public Offering
Cantor Equity Partners II, Inc. (NASDAQ:CEPT) (the "Company") announced today the pricing of its upsized initial public offering of 24,000,000 Class A ordinary shares at $10.00 per share. The shares are expected to be
KBRA Assigns Preliminary Ratings to PMT Loan Trust 2025-INV5 (PMTLT 2025-INV5)
KBRA assigns preliminary ratings to 62 classes of mortgage backed notes from PMT Loan Trust 2025-INV5 (PMTLT 2025-INV5), a prime RMBS transaction sponsored by PennyMac Corp. (PennyMac), an indirect, wholly-owned
M-tron Industries, Inc. to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call on May 14, 2025
M-tron Industries, Inc. (NYSE:MPTI) ("Mtron" or the "Company") will report financial results for the first quarter ended March 31, 2025, after the market closes on Tuesday, May 13, 2025. Mtron's press
PennyMac Financial Services, Inc. Announces Upsizing and Pricing of Private Offering of $850 Million of Senior Notes
PennyMac Financial Services, Inc. (NYSE:PFSI) and its subsidiaries (the "Company") today announced the pricing of its previously announced offering of $850 million aggregate principal amount of 6.875% Senior Notes due
Forum Energy Technologies Announces First Quarter 2025 Results; Maintains Full Year 2025 Cash Flow Guidance
Orders: $201 million and book-to-bill of 104% Revenue: $193 million Net income: $1 million, or $0.09 per diluted share Adjusted EBITDA: $20 million Operating cash flow and free cash flow: $9 million and $7
Gores Holdings X, Inc. Announces Pricing of Upsized $312 Million Initial Public Offering
Gores Holdings X, Inc. (the "Company"), a blank check company sponsored by an affiliate of The Gores Group and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase,